Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cells

被引：5
|
作者：
Sek, Kevin [1 ,2 ]
Chan, Cheok Weng [1 ,2 ]
Beavis, Paul A. [1 ,2 ]
Darcy, Phillip K. [1 ,2 ,3 ,4 ]
机构：
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[4] Monash Univ, Dept Immunol, Clayton, Vic, Australia
来源：
CANCER CELL | 2021年 / 39卷 / 12期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
CAR-T CELLS;
D O I：
10.1016/j.ccell.2021.10.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this issue of Cancer Cell, Xue et al. demonstrate that adoptive transfer of tumor-specific Th9 cells can eradicate established tumors containing antigen-loss-variant cells (ALVs) through both direct killing and bystander effects mediated by intratumoral accumulation of extracellular ATP (eATP) that promotes monocyte infiltration and stimulation of IFN alpha/beta production.
引用
收藏
页码：1564 / 1566
页数：3
相关论文
共 50 条
  • [1] Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells
    Xue, Gang
    Zheng, Ningbo
    Fang, Jing
    Jin, Guangxu
    Li, Xiaoyin
    Dotti, Gianpietro
    Yi, Qing
    Lu, Yong
    CANCER CELL, 2021, 39 (12) : 1610 - +
  • [2] Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to restrain acquired resistance from antigen-loss-variant tumor cells
    Lu, Yong
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response
    Lorvik, Kristina Berg
    Hammarstrom, Clara
    Fauskanger, Marte
    Haabeth, Ole Audun Werner
    Zangani, Michael
    Haraldsen, Guttorm
    Bogen, Bjarne
    Corthay, Alexandre
    CANCER RESEARCH, 2016, 76 (23) : 6864 - 6876
  • [4] Cancer immunotherapy by adoptive transfer of tumor-specific Th2 cells
    Corthay, A.
    Hammarstrom, C.
    Fauskanger, M.
    Haabeth, O. A. W.
    Zangani, M.
    Haraldsen, H.
    Bogen, B.
    Lorvik, K. B.
    IMMUNOLOGY, 2012, 137 : 706 - 706
  • [5] Cure of murine medulloblastoma by adoptive transfer of tumor-specific T cells
    Nicholson, Cameron L.
    Plautz, Gregory E.
    BLOOD, 2007, 110 (11) : 301B - 301B
  • [6] Characterization of a tumor-specific antigen expressing on Chang hepatoma ascites cells
    Lin, SC
    Roffler, SR
    Cheng, TL
    Chang, KT
    Chang, JP
    Wang, JJ
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2000, 33 (05) : 367 - 375
  • [7] IL-9 and Th9 Cells in Tumor Immunity
    He, Ying
    Dong, Lin
    Cao, Yejin
    Bi, Yujing
    Liu, Guangwei
    TUMOR MICROENVIRONMENT: THE ROLE OF INTERLEUKINS, PT A, 2020, 1240 : 35 - 46
  • [8] TH9 cells in anti-tumor immunity
    Thaiz Rivera Vargas
    Etienne Humblin
    Frédérique Végran
    François Ghiringhelli
    Lionel Apetoh
    Seminars in Immunopathology, 2017, 39 : 39 - 46
  • [9] TH9 cells in anti-tumor immunity
    Vargas, Thaiz Rivera
    Humblin, Etienne
    Vegran, Frederique
    Ghiringhelli, Francois
    Apetoh, Lionel
    SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (01) : 39 - 46
  • [10] Induction of tumor-specific T cell response by cognating tumor cells with foreign antigen-primed Th cells
    Cheng, TY
    Wu, JT
    Lin, RH
    INTERNATIONAL IMMUNOLOGY, 1998, 10 (10) : 1397 - 1406
12345